Literature DB >> 33237453

The circular RNAs differential expression profiles in the metastasis of salivary adenoid cystic carcinoma cells.

Rui Ju1,2, Yanling Huang1,2, Zeyou Guo1,2, Lu Han1,2, Suhui Ji2, Luyang Zhao2, Jie Long3,4.   

Abstract

In order to reveal circular RNAs (circRNAs) differential expression profiles and investigate the function and mechanism of circRNAs in the metastasis of salivary adenoid cystic carcinoma (SACC), microarray was used to detect differentially expressed circRNAs in SACC-83 and SACC-lung metastasis (LM) cell lines. Up-regulated circRNAs were analyzed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to further predict their function. Expression of candidate circRNA and microRNA (miRNA) was determined using quantitative real-time polymerase chain reaction (qRT-PCR). Constructed circRNA-miRNA-mRNA co-expression network was based on TargetScan, miRanda databases. Wound healing and transwell assays were completed to examine the effects of hsa_circRNA_001982 and miR-181a-5p on cell migration and invasion. qRT-PCR confirmed hsa_circRNA_092556, hsa_circRNA_101379, and hsa_circRNA_001982 up-regulation in SACC-LM. miR-181a-5p was down-regulated in SACC-LM and correlated with up-regulated hsa_circRNA_001982. Wound healing and transwell assays indicated that silencing hsa_circRNA_001982 inhibited the migration and invasion of the SACC-LM cells. Furthermore, over-expression of hsa_circRNA_001982 promoted the migration and invasion of SACC-83 cells. Interestingly, up-regulation or down-regulation of miR-181a-5p led to the opposite result in wound healing and transwell assays. Overall, differential expression circRNA profiles in SACC-83 and SACC-LM cells may reveal potential targets and a novel mechanism of circRNAs in the metastasis of SACC. Moreover, the interaction of hsa_circRNA_001982/miR-181a-5p is closely related to the metastasis of SACC cells.

Entities:  

Keywords:  Expression profiles; SACC; circRNA; miRNA

Mesh:

Substances:

Year:  2020        PMID: 33237453     DOI: 10.1007/s11010-020-03989-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  6 in total

Review 1.  Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives.

Authors:  Roberta Brusa; Francesca Magri; Nereo Bresolin; Giacomo Pietro Comi; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2020-04-29       Impact factor: 9.261

2.  Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism.

Authors:  Ling-Yan Cai; Shi-Jie Chen; Sen-Hao Xiao; Qin-Juan Sun; Chen-Hong Ding; Bai-Nan Zheng; Xin-Yan Zhu; Shu-Qing Liu; Feng Yang; Ya-Xi Yang; Bing Zhou; Cheng Luo; Xin Zhang; Wei-Fen Xie
Journal:  Cancer Res       Date:  2020-12-23       Impact factor: 12.701

3.  LncRNA PART1 promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-17-5p.

Authors:  Yeye Chen; Xiaoyun Zhou; Cheng Huang; Li Li; Yingzhi Qin; Zhenhuan Tian; Jia He; Hongsheng Liu
Journal:  J Cell Biochem       Date:  2020-12-27       Impact factor: 4.429

Review 4.  Gene regulation by long non-coding RNAs and its biological functions.

Authors:  Luisa Statello; Chun-Jie Guo; Ling-Ling Chen; Maite Huarte
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

5.  PRRX1-induced epithelial-to-mesenchymal transition in salivary adenoid cystic carcinoma activates the metabolic reprogramming of free fatty acids to promote invasion and metastasis.

Authors:  Ya-Ping Jiang; Ya-Ling Tang; Sha-Sha Wang; Jia-Shun Wu; Mei Zhang; Xin Pang; Jing-Biao Wu; Yu Chen; Ya-Jie Tang; Xin-Hua Liang
Journal:  Cell Prolif       Date:  2019-10-27       Impact factor: 6.831

Review 6.  FOXO transcription factor family in cancer and metastasis.

Authors:  Yannasittha Jiramongkol; Eric W-F Lam
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.